MedPath

The maternal cardiovascular effect of phenylephrine-ephedrine compared to ephedrine protocols for cesarean section under spinal anesthesia: a multicenter randomized controlled trial

Phase 3
Recruiting
Conditions
Hypotension during spinal anesthesia for cesarean secttion
Registration Number
TCTR20191210002
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
316
Inclusion Criteria

18 years of age and older
scheduled for elective cesarean section in official time
37-42 weeks gestational age
ASA physical status I-II
normal singleton

Exclusion Criteria

multiple gestation
complicated pregnancy eg. placenta previa, abruptio placenta
preexisting cardiovascular disease, renal and liver impairment, thyroid dysfunction, increased intraocular pressure
ongoing infection
history of drug abuse, MAOI or TCA group 1 month prior to delivery, vasopressor agent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
average maternal heart rate after spinal anesthesia until operation end beat per minute
Secondary Outcome Measures
NameTimeMethod
average maternal systolic blood pressure after spinal anesthesia until operation end mmHg,severity of nausea and vomiting after spinal anesthesia until operation end score,satisfaction after spinal anesthesia before delivery VAS,total dose of vasopressor after spinal anesthesia until operation end mg, mcg,atropine used after spinal anesthesia until umbilical cord clamping mg,arrhythmia after spinal anesthesia until operation end occurance,Apgar score 1st,5th minutes post-delivery score
© Copyright 2025. All Rights Reserved by MedPath